Table 3 Univariate analyses of prognostic factors for DFS in patients with malignant melanoma
Factors | Median DFS (months) | P value |
|---|---|---|
Histological type | Â | Â |
   ALM | 20.0 | 0.716 |
   NM | 20.0 |  |
   SSM | 28.0 |  |
   LMM | 16.0 |  |
   MCM | 17.0 |  |
   Unclassifiable | 16.0 |  |
Primary location | Â | Â |
   Trunk | 25.0 | 0.721 |
   H&N | 16.0 |  |
   Palmoplantar/Subungual | 20.0 |  |
   Upper/Lower limb | 21.0 |  |
   Mucosal | 17.0 |  |
   Unkown | 16.0 |  |
Stage | Â | Â |
   I | 44.0 | < 0.001 |
   II | 21.0 |  |
   III | 13.0 |  |
Gender | Â | Â |
   Male | 16.0 | 0.035 |
   Female | 22.0 |  |
Age | Â | Â |
   ≤ 65 y | 20.0 | 0.709 |
   > 65 y | 20.0 |  |
Surgery | Â | Â |
   Local resection | 15.0 | < 0.001 |
   Extended resection | 24.0 |  |
   Ext. resection w/nodal dissection | 13.0 |  |
Adjuvant therapy | Â | Â |
   None | 13.0 | < 0.001 |
   Chemotherapy | 20.0 |  |
   Chemoradiation | 29.0 |  |
   IFN | Not reached |  |
   Radiation | 23.0 |  |
Ulceration | Â | Â |
   with | 20.0 | 0.488 |
   without | 20.0 |  |
Breslow thickness* | Â | Â |
   ≤ 1 mm | 38.0 | 0.178 |
   1-4 mm | 21.0 |  |
   > 4 mm | 13.0 |  |